Navigation Links
Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
Date:2/5/2008

ST. LOUIS, Feb. 5 /PRNewswire-FirstCall/ -- Young Innovations, Inc. (Nasdaq: YDNT) today announced results for the quarter and year ended December 31, 2007.

Sales for the fourth quarter of 2007 were $25.0 million, an increase of $0.2 million, or 0.8%, from the $24.8 million reported in the fourth quarter of 2006. Income from operations decreased 17.8% from $6.2 million in the fourth quarter of 2006 to $5.1 million in the fourth quarter of 2007. Net income declined 3.5% to $3.6 million, compared with $3.7 million in the fourth quarter of 2006. Diluted earnings per share increased 7.5% in the fourth quarter of 2007 to $0.43 from $0.40 in the prior year quarter. Diluted earnings per share were affected by equity compensation expense of $0.02 and $0.00 for the quarters ended December 31, 2007 and 2006, respectively.

Sales for the year ended December 31, 2007, were $97.4 million, up 7.3% from $90.8 million in the prior year. Income from operations decreased 11.6% from $23.5 million in 2006 to $20.8 million in 2007. Net income for fiscal year 2007 was $12.9 million, down 12.5% from $14.8 million in the prior year. Diluted earnings per share were $1.44 for the twelve months ended December 31, 2007, a decrease of 10.6% from $1.61 in 2006. Diluted earnings per share were affected by equity compensation expense of $0.08 and $0.02 for 2007 and 2006, respectively. The results for the year were affected by the acquisition of the assets of Microbrush, Inc. and Microbrush International, Ltd. (collectively "Microbrush"), completed on July 31, 2006, and August 18, 2006, respectively. Microbrush contributed approximately $14.5 million in sales in 2007, as compared to $5.0 million in sales in 2006.

Earnings per share in the quarter and
'/>"/>

SOURCE Young Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Air pollution linked to cardiovascular risk indices in healthy young adults
2. Urban Smog Tough on Young Adults Hearts
3. Male deer are born to live fast, die young
4. Bipolar Diagnoses in Younger People Show Huge Increase
5. HealthInsuranceFinders.com Launches Video Contest for Young Directors
6. Nuclear medicine approach can be first choice for excluding pulmonary embolism in young women
7. New HIV diagnoses rising in New York City among young men who have sex with men
8. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
9. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
10. Young Children Thrive on 30,000 Words a Day
11. Young Twin Cities Boy Shows There is Life After Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...n. 8 Press Ganey Associates, Inc.,...ology (PatientFlow), a,leading provider of patien....,The Boston-based company specializes in improvi...tions for patient flow issues such as emergency ro...ed surgeries, and lack of,available ICU and hospi...
(Date:1/7/2009)... the time pancreatic cancer is discovered, it is o...Patrick Swayze) and survival rates are low. Dr. A... in pancreatic, liver and gastrointestinal (GI) ca...reated a groundbreaking team approach to improve c...s for patients. , Morri...
(Date:1/7/2009)...containing health care costs could have the uninte...y, impairing quality and perhaps even increasing c...sicians suggest in a New England Journal of Medic...l economics and psychology, Pamela Hartzband, MD a...ning a monetary value to every aspect of a physici...
(Date:1/7/2009)... 7 Non-profits Medical Tourism Association ( www....th Care City ( www.monterreyciudaddelasalud.com....in America Medical Tourism and Health Tourism Cong...y, Mexico at the Intercontinental Presidente. Mon...medical tourism in Latin America, has several JCI ...
Breaking Medicine News(10 mins):Health News:Press Ganey Acquires PatientFlow Technology 2Health News:Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes 2Health News:Cost containment focus could have consequences for health care delivery 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 3Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 4
...tential flu pandemic showed that nearly 62 million...ileged nations, could pay// with their life. The... Spanish flu, which wiped out nearly 20 million pe...om the Harvard School of Public Health and the Uni...
... pain are effective, a new review of studies has f...ogical outcomes such as// depression and health-re...experience of pain. “Because this analysis was b...ive than previous reviews, we have the best eviden...
...ient may be forced to undertake treatment in spite... painful radiotherapy. Having beaten the condition...nning over six years, Leah has been confronted by ... to her parents Kathryn and Mark Richards, the att...
...atry published a study which proved that Botox- th...ting wrinkled skin could ease writer’s cramp as we... contractions of the hand, arms or fingers which c...ur during manual work. Some people learn to write ...
Other Medicine News:Health News:Psychological Treatments Improve Outcomes for Back Pain Sufferers 2Health News:Psychological Treatments Improve Outcomes for Back Pain Sufferers 3
(Date:1/7/2009)...wire-FirstCall/ -- Eli Lilly and Company,(NYSE: ... response letter from,the U.S. Food and Drug Admi...tion (LAI) for acute and maintenance treatment of ...ork with the agency on the new drug,application (...onal clinical trials for the continued,review of ...
(Date:1/7/2009)...re-USNewswire/ -- Scientists have identified mutat...elapse in children with acute lymphoblastic leukem...rther research is needed to determine how changes ...eukemia relapse, the findings are likely to provid...the risk of treatment failure. By using a molecula...
(Date:1/7/2009)...ncrease , , WHITE PLAINS, N.Y., Jan. 7 /PRNewsw...rm that the decades-long rise in the United States...s than ever at increased risk of death and disabil... 543,000 babies were born too soon in 2006, accord...which today released "Births: Final data for 2006,...
(Date:1/7/2009)...re/ -- ImQuest Life Sciences announced today the s...Food and Drug Administration to initiate human cli...hibitor IQP-0410. ImQuest anticipates initiating t... IQP-0410 is a novel small molecule inhibitor of H... transcriptase inhibitor (NNRTI). The compound pos...
Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Preterm Births Rise 36 Percent Since Early 1980s 2ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Sleep is poor among hospitalized pediatric patients and their parents 21404 1Sleep is poor among hospitalized pediatric patients and their parents 21404 2Sleep is poor among hospitalized pediatric patients and their parents 21404 3Treatment at an AASM accredited sleep center improves long term CPAP compliance 21401 1Treatment at an AASM accredited sleep center improves long term CPAP compliance 21401 2Treatment at an AASM accredited sleep center improves long term CPAP compliance 21401 3Paramount Farms Establishes Scientific Advisory Board to Advance Understanding of the Health Benefits of Pistachios 21398 1Paramount Farms Establishes Scientific Advisory Board to Advance Understanding of the Health Benefits of Pistachios 21398 2New VeriEye SDK from Neurotechnology Enables Development of Reliable Cost effective Biometric Iris Recognition Systems 5892 1New VeriEye SDK from Neurotechnology Enables Development of Reliable Cost effective Biometric Iris Recognition Systems 5892 2New VeriEye SDK from Neurotechnology Enables Development of Reliable Cost effective Biometric Iris Recognition Systems 5892 3
...S WIRE)--May 14, 2007 - Oculus Innovative,Sciences...cyn,Technology was the subject of a poster present... (EWMA) conference that was held in,Glasgow, Scotl... Results About an Antimicrobial,Solution in the Tr...ng & Harding infection criteria to evaluate th...
...-May 15, 2007 - Gemin X Biotechnologies,Inc. annou...Blood,demonstrated that its lead compound, obatocl...le Cell Lymphoma (MCL) cell lines and,primary cell...small,molecule specifically designed to inhibit al...validated cancer target, thus restoring,the natura...
Other Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3
...ttors , , Available with five different volume ra...ors can effectively meet the demands of any applic...nd superior functionality as our multichannel line...a wide range of liquid handling tasks including:,...
... high performance electronic pipetting!, Soft, f...educe hand fatigue and strain , Stress-free tip ...ding for easy volume identification , Accepts un...on AdvanTip Low Retention and AdvanTip Precision P...
... high performance electronic pipetting! , Soft, ...reduce hand fatigue and strain, Stress-free tip ...ing for easy volume identification, Accepts univ... AdvanTip Low Retention and AdvanTip Precision Pip...
The Finnpipette BioControl is a major step forward in electronic pipetting technology. A complete liquid handling system - with one universal handle and twelve interchangeable tip cone modules. All f
Medicine Products: